Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Mozambique

Mozambique

The COVID-19 Vaccines market in Mozambique is anticipated to witness a significant surge in revenue, projected to reach US$28.89m by the year 2024.
Moreover, this market is expected to exhibit a noteworthy annual growth rate (CAGR 2024-2029) of -15.78%.
As a consequence, the market volume is predicted to escalate to US$12.24m by 2029.
In terms of global comparison, United States is projected to generate the highest revenue in this market, amounting to US$4,389,000.00k in the year 2024.
"Mozambique's COVID-19 vaccine market is witnessing a surge in demand as the government accelerates vaccination efforts and prioritizes remote and underserved areas."

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

Mozambique, like many other countries, has been affected by the COVID-19 pandemic. As the country strives to contain the spread of the virus, the demand for COVID-19 vaccines has increased. Here are some insights into the trends and developments in the COVID-19 vaccines market in Mozambique.

Customer preferences: Mozambique, like many other African countries, has a preference for vaccines that have been approved by the World Health Organization (WHO). The country has received doses of the AstraZeneca vaccine through the COVAX facility, which is a global initiative that aims to ensure equitable access to COVID-19 vaccines. The country has also received doses of the Sinopharm vaccine from China.

Trends in the market: The demand for COVID-19 vaccines in Mozambique has been increasing, as the country tries to vaccinate its population. However, the supply of vaccines has been limited, which has led to a slow rollout of the vaccination program. The government is working to secure more doses of the vaccine to speed up the vaccination process.

Local special circumstances: Mozambique has a high poverty rate, and many people live in rural areas with limited access to healthcare facilities. This has made it challenging to distribute vaccines to all parts of the country. The government has been working to overcome these challenges by setting up vaccination centers in rural areas and using mobile teams to reach remote communities.

Underlying macroeconomic factors: Mozambique is a low-income country with a small economy. The COVID-19 pandemic has had a significant impact on the country's economy, with many businesses closing down and people losing their jobs. The government has been working to mitigate the impact of the pandemic on the economy by providing support to businesses and households. However, the limited resources have made it challenging to secure enough vaccines to vaccinate the entire population.In conclusion, the COVID-19 vaccines market in Mozambique is still in its early stages, with limited supply and a slow rollout of the vaccination program. The government is working to secure more doses of the vaccine and overcome the challenges of distributing the vaccine to all parts of the country. The high poverty rate and limited resources have made it challenging to vaccinate the entire population, but the government is committed to ensuring that everyone has access to the vaccine.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.